FDA Will Drive Changes for Contract Business

Pharmaceutical Technology, Pharmaceutical Technology-11-02-2003, Volume 27, Issue 11

As FDA tries to bring pharmaceutical manufacturing into the 21st century, competitive dynamics in contract manufacturing are likely to change in favor of companies that have greater manufacturing expertise and the means to invest in new technologies.

Related Content:

OutsourcingOutsourcing OutlookPharmaceutical Technology-11-02-2003
How Integrated Project Delivery Enables Speed: A Phase-By-Phase Guide
Robust Bioanalytical Studies Can Aid in Regulatory Submissions
Drug Digest: Sterilization’s Horizon: Improving Automation, Single-Use Technologies, and Annex 1